Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06874101 · ClinicalTrials.gov registry record · NA
Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease Patients
A NA study, sponsored by Barron Associates.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06874101 is a NA study that has not yet begun recruiting, run by Barron Associates. The registered enrollment target is 100 participants.
The verdict
NCT06874101, a NA study, has not yet begun recruiting, sponsored by Barron Associates.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a device called "ROAM" that is being developed to see how patients with chronic obstructive pulmonary disease (COPD) use oxygen therapy over a long period of time. This study will focus on evaluating the ROAM device, which will be attached to your oxygen source. The question that the study aims to answer is: will patients who receive daily adherence feedback from the ROAM have increased adherence to their prescribed long term oxygen therapy regimens? Researchers will compare the amount of time using oxygen and attitudes about oxygen therapy observed in a group that receives feedback from ROAM, and a control group that does not receive feedback. Participants will have their oxygen supplies fitted with the ROAM device and then use their oxygen as usual for the 5-week study duration. Participants in the study group will have access to information about their oxygen usage and pulse oximetry levels. All participants will attend two in-clinic sessions of about an hour each, and will complete questionnaires at the beginning and end of the study.
Interventions
- DEVICE Sham Comparator
- DEVICE Activated ROAM System with User Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06874101
The ClinicalTrials.gov registry entry for NCT06874101 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barron Associates, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Comparator is the first listed.
NCT06874101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06874101 about?
NCT06874101 is a clinical study titled "Respiratory Oxygen Adherence Monitor for Chronic Obstructive Pulmonary Disease Patients". The goal of this clinical trial is to test a device called "ROAM" that is being developed to see how patients with chronic obstructive pulmonary disease (COPD) use oxygen therapy over a long period of time. This study will focus on evaluating the ROAM device, which will be attached to your oxygen so...
What is the current status of trial NCT06874101?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-05-01. Estimated completion is 2026-04-30.
What interventions are being tested in trial NCT06874101?
The interventions under investigation include: Sham Comparator (DEVICE), Activated ROAM System with User Feedback (DEVICE).
Who is sponsoring clinical trial NCT06874101?
This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.